Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P.vivax in Aotus monkeys. (Q48008497)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 March 2005

Language	Label	Description	Also known as
English	Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P.vivax in Aotus monkeys.	scientific article published on 19 March 2005

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P.vivax in Aotus monkeys. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

Plasmodium vivax

0 references

1 reference

based on heuristic

inferred from title

Gabriela Delgado

object named as

Gabriela Delgado

2

0 references

Manuel-Alfonso Patarroyo

6

object named as

Manuel A Patarroyo

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

author name string

Carlos A Barrero

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

Adriana Y Sierra

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

Yolanda Silva

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

Carlos Parra-Lopez

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

language of work or name

0 references

publication date

19 March 2005

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

23

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

31

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

4048-4053

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

Malaria: new developments in treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Functional and structural similarity of V gamma 9V delta 2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Sequence and diversity of MHC DQA and DQB genes of the owl monkey Aotus nancymaae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Characterizing T-cell receptor gamma-variable gene in Aotus nancymaae owl monkey peripheral blood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Sequence and diversity of DRB genes of Aotus nancymaae, a primate model for human malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Modified merozoite surface protein-1 peptides with short alpha helical regions are associated with inducing protection against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Plasmodium vivax under the microscope: the Aotus model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Are trials in New World monkeys on the critical path for blood-stage malaria vaccine development?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Immunogenic properties of the Plasmodium vivax vaccine candidate MSP1(19) expressed as a secreted non-glycosylated polypeptide from Pichia pastoris.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

A highly infective Plasmodium vivax strain adapted to Aotus monkeys: quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Proliferative response of peripheral blood lymphocytes to mitogens in the owl monkey Aotus nancymae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

Vaccination for vivax malaria: targeting the invaders

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.02.012

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

release_2m7rrh5parhstiprvnzuaghqyy

0 references

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15893858

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48008497&oldid=1842174829"